Topicort and Thin bones - a phase IV clinical study of FDA data

Summary:

Thin bones is reported as a side effect among people who take Topicort (desoximetasone), especially for people who are female, 50-59 old, also take Arava, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Thin bones when taking Topicort. It is created by eHealthMe based on reports of 3,416 people who have side effects when taking Topicort from the FDA, and is updated regularly.

What is Topicort?

Topicort has active ingredients of desoximetasone. eHealthMe is studying from 3,423 Topicort users. Check the latest studies of Topicort.

What is Thin bones?

Thin bones is found to be associated with 2,433 drugs and 1,925 conditions by eHealthMe. Check the latest studies of Thin bones.

On Apr, 02, 2026

3,416 people reported to have side effects when taking Topicort.
Among them, 94 people (2.75%) have Thin bones.

Among these 94 people:

What is the gender of people who have Thin bones when taking Topicort? *

female: 100 %
male: 0.0 %

What is the age of people who have Thin bones when taking Topicort? *

What are other drugs people take besides Topicort? *

What are other side effects people have besides Thin bones? *

High Blood Cholesterol: 87 people, 92.55%
Pneumonia: 86 people, 91.49%
Hair Loss: 85 people, 90.43%
Headache (pain in head): 85 people, 90.43%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 85 people, 90.43%
Drug Intolerance (drug sensitivity): 84 people, 89.36%
Retinitis (inflammation of the retina in the eye): 83 people, 88.30%
Dizziness: 83 people, 88.30%
Foot Deformity (functional disability of foot): 82 people, 87.23%
Visual Impairment: 82 people, 87.23%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 92 people, 97.87%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 73 people, 77.66%
Ankylosing Spondylitis (type of arthritis affecting the spine): 59 people, 62.77%
Psoriasis (immune-mediated disease that affects the skin): 59 people, 62.77%
Joint Pain: 54 people, 57.45%
Pain: 46 people, 48.94%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 43 people, 45.74%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 17 people, 18.09%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 9.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Topicort and have Thin bones?

- Check whether Thin bones is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Topicort:

Topicort (3,423 reports)

Thin bones treatments and more:

Thin bones (290,733 reports)

Browse all side effects of Topicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thin bones:

Thin bones (2,433 drugs)

Browse all the conditions that are associated with Thin bones:

Thin bones (1,925 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on desoximetasone (the active ingredients of Topicort) and Topicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.